Advertisement

Medicinal Chemistry Research

, Volume 28, Issue 8, pp 1319–1337 | Cite as

Fluorophenols bearing nitrogenated heterocycle moieties, a class of novel Keap1-Nrf2 protein-protein interaction inhibitors: synthesis, antioxidant stress screening and molecular docking

  • Xiu E Feng
  • De Peng Kong
  • Shu Rong Ban
  • Rui Ge
  • Qing Shan LiEmail author
Original Research
  • 9 Downloads

Abstract

In the present study, we introduced the nitrogenated heterocycles and fluorine atoms into the 2,5′-dibromo-4,5,2′-trihydroxyl diphenylmethanone (LM49), a bromophenol analog previously reported for its strong antioxidant ability involving in the Keap1–Nrf2 pathway. Twenty-seven fluorophenols 6a–6g, 8a–8k, 10a–10g, and 12a–12b were prepared, evaluated for their antioxidant activity in EA.hy926 cells, and investigated their interacted approach and probable mode of action with key protein Keap1 by molecular docking. Fluorophenols 6f, 8d, 8f, 8h, and 8i with EC50 values ranging from 0.82 to 6.71 µM were found to be more active compared with the standard control quercetin (EC50 = 18 µM). Among them, compound 8h with an EC50 value of 0.82 µM showed the identical activity to lead compound LM49 (EC50 = 0.7 µM). Moreover, the preferable water solubility and forming salt possibility of 8h contribute to its druggability. Further molecular docking of the optimal compound 8h with key protein Keap1 indicated that 8h stably bonded to the receptor protein by the formation of hydrogen bonds, the conjugated six-membered ring was close to the key residue Arg-415 attached to the Nrf2 on Keap1-Kelch, affecting its properties, and the change leaded to the dissociation of Nrf2 from the junction with Keap1-Kelch into the nucleus exerting its antioxidant protective effect. This study introduced a class of fluorophenols containing nitrogenated heterocycles for the development of novel Keap1-Nrf2 protein–protein interaction (PPI) inhibitors. Keap1-Kelch is suggested the most potential target protein for such class of halophenols.

Keywords

Fluorophenol Synthesis Nitrogenated heterocycle Molecular docking Antioxidant activity 

Notes

Acknowledgements

This work was financially supported by the National Natural Science Foundation of China (No. 81473100), the Drug Innovation Major Project of China (No. 2018ZX09711-001-001-017), Key Research and Development Plan (key project) of Shanxi Province (No. 201703D111033), Shanxi Coal Base Key Research Projects (No. MJH2014-14), Shanxi Medical University Doctor Startup Fund (No. B03201213), the Program for the Top and Key Science and Technology Innovation Teams of Shanxi Province (No. 2014131012).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

44_2019_2376_MOESM1_ESM.pdf (219 kb)
Supplementary Information
44_2019_2376_MOESM2_ESM.pdf (107 kb)
Supplementary Information
44_2019_2376_MOESM3_ESM.pdf (45 kb)
Supplementary Information
44_2019_2376_MOESM4_ESM.pdf (216 kb)
Supplementary Information
44_2019_2376_MOESM5_ESM.pdf (115 kb)
Supplementary Information
44_2019_2376_MOESM6_ESM.pdf (96 kb)
Supplementary Information
44_2019_2376_MOESM7_ESM.pdf (203 kb)
Supplementary Information
44_2019_2376_MOESM8_ESM.pdf (93 kb)
Supplementary Information
44_2019_2376_MOESM9_ESM.pdf (90 kb)
Supplementary Information
44_2019_2376_MOESM10_ESM.pdf (238 kb)
Supplementary Information
44_2019_2376_MOESM11_ESM.pdf (110 kb)
Supplementary Information
44_2019_2376_MOESM12_ESM.pdf (76 kb)
Supplementary Information
44_2019_2376_MOESM13_ESM.pdf (229 kb)
Supplementary Information
44_2019_2376_MOESM14_ESM.pdf (93 kb)
Supplementary Information
44_2019_2376_MOESM15_ESM.pdf (80 kb)
Supplementary Information

References

  1. Abed DA, Goldstein M, Albanyan H, Jin H, Hu LQ (2015) Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents. Acta Pharm Sin B 5:285–299CrossRefGoogle Scholar
  2. Ali M, Ali S, Khan M, Rashid U, Ahmad M, Khan A, Al-Harrasi A, Ullah F, Latif A (2018) Synthesis, biological activities, and molecular docking studies of 2-mercaptobenzimidazole based derivatives. Bioorg Chem 80:472–479CrossRefGoogle Scholar
  3. Atul DJ, Haranatha P, Benjamin GR, Laura K, Julia PL, Aya FR, Hyun L, Aleksej K, Andrew DM, Sekhar PR, Terry WM (2015) Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators. Eur J Med Chem 103:252–268CrossRefGoogle Scholar
  4. Balaydın HT, Entürk MS, Göksu S, Menzek A (2012) Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols and their derivatives including natural products: Vidalol B. Eur J Med Chem 54:423–428CrossRefGoogle Scholar
  5. Emilia F, Carlotta C, Franco B, Laura C, Erika P, Nadia B, Guido V, Pierluigi Q, Gaetano D, Marie Pierre K (2017) Nonviral gene-delivery by highly fluorinated gemini bispyridinium surfactant-based DNA nanoparticles. J Colloid Interface Sci 487:182–191CrossRefGoogle Scholar
  6. Feng XE, Liang TG, Gao J, Kong DP, Ge R, Li QS (2017) Heme oxygenase-1, a key enzyme for the cytoprotective actions of halophenols by upregulating Nrf2 expression via activating Erk1/2 and PI3K/Akt in EA.hy926 cells. Oxid Med Cell Longev 2017:7028478Google Scholar
  7. Hoffmann M, Rychlewsk J (2002) When, in the context of drug design, can a fluorine atom successfully substitute a hydroxyl group? Int J Quantum Chem 89:419–427CrossRefGoogle Scholar
  8. Hu GQ, Hou LL, Xie SQ, Du GJ, Huang WL, Zhang HB (2009) Synthesis and bioactivity of asymmetrical bis-heterocyclic substituted s-triazolothiadiazole piperazine derivatives. Chinese J Appl Chem 1:63–66Google Scholar
  9. Hu LQ, Magesh S, Chen L, Wang LL, Lewis TA, Chen Y, Khodier C, Inoyama D, Beamer LJ, Emge TJ, Shen J, Kerrigan JE, Kong ANT, Dandapani S, Palmer M, Schreiber SL, Munoz B (2013) Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein-protein interaction. Bioorg Med Chem Lett 23:3039–3043CrossRefGoogle Scholar
  10. Ishi T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275:16023–16029CrossRefGoogle Scholar
  11. Gribble GW (2000) The natural production of organobromine compounds. Environ Sci Pollut R 7:37–49CrossRefGoogle Scholar
  12. Kirk KL (2006) Fluorine in medicinal chemistry: recent therapeutic applications of fluorinated small molecules. J Fluorine Chem 127:1013–1029CrossRefGoogle Scholar
  13. Lee JC, Hou MF, Huang HW, Chang FR, Yeh CC, Tang JY, Chang HW (2013) Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int 13:55CrossRefGoogle Scholar
  14. Luana Maria Castelo Melo S, Vilma L, Márjory Lima H, Paula Goes P, José Ariévilo Gurgel R, Maria Edna Pereira L, Norma Maria Barros B (2010) Antinociceptive and anti-inflammatory activities of lectin from marine red alga pterocladiella capillacea. Biol Pharm Bull 33:830–835CrossRefGoogle Scholar
  15. Öztaşkın N, Çetinkay Y, Taslimi P, Göksu S, Gülçin I (2015) Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives. Bioorg Chem 60:49–57CrossRefGoogle Scholar
  16. Schabe MJ, Donnelly VM, Kornblit A, Tai WW (2002) Determination of electron temperature, atomic fluorine concentration, and gas temperature in inductively coupled fluorocarbon/rare gas plasmas using optical emission spectroscopy. J Vac Sci Technol A 20:555–563CrossRefGoogle Scholar
  17. Shukla PK, Verma A, Mishra P (2017) Significance of nitrogen heterocyclic nuclei in the search of pharmacological active compounds. In: Shukla RP, Mishra RS, Tripathi AD, Yadav AK, Tiwari M, Mishra RR (eds), New perspective in agriculture and human health (Vol. 3). Bharti Publication, New Delhi, pp 100–126Google Scholar
  18. Thomas GD, William EW, Joseph EC, Charlotte GJ, Keisha H, Rachel LM, David N, Sharna JR, Caroline R, Gordon S, Henriette Maria Gerarda W, Alison J-AW, Joshua EC, Jen-Pyng K, John GY, Heidi GF, Yolanda S, Joseph PF, Brian JB, Gregory AL, Patricia LP, Hongxing Y, James FC, Tom Daniel H, Jeffrey KK (2016) Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1: NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery. J Med Chem 59:3991–4006CrossRefGoogle Scholar
  19. Wang W, Okada Y, Shi H, Wang YQ, Okuyama T (2005) Structures and aldose reductase inhibitory effects of bromophenols from the red alga symphyocladia latiuscula. J Nat Prod 68:620–622CrossRefGoogle Scholar
  20. Zhao WY, Feng XE, Ban SR, Lin WH, Li QS (2010) Synthesis and biological activity of halophenols as potent antioxidant and cytoprotective agents. Bioorg Med Chem Lett 20:4132–4134CrossRefGoogle Scholar
  21. Zheng FL, Ban SR, Feng XE, Zhao CX, Lin WH, Li QS (2011) Synthesis and in vitro protein tyrosine kinase inhibitory activity of furan-2-yl(phenyl)methanone derivatives. Molecules 16:4897–4911CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Xiu E Feng
    • 1
  • De Peng Kong
    • 1
  • Shu Rong Ban
    • 1
  • Rui Ge
    • 1
  • Qing Shan Li
    • 1
    • 2
    Email author
  1. 1.School of Pharmaceutical ScienceShanxi Medical UniversityTaiyuanChina
  2. 2.Shanxi Key laboratory of Chronic Inflammatory Targeted Drugs, School of Chinese Materia MedicaShanxiUniversity of Traditional Chinese MedicineJinzhongChina

Personalised recommendations